Bioethics News

Risky Stem Cell Procedure for ALS May Be Done Safely, Study Shows

June 30, 2016

(The Verge) – A complicated procedure for transplanting human stem cells into the spinal cord of patients with a fatal neurodegenerative disease may be done safely, new research shows. Although it’s unclear whether the stem cell treatment can actually slow down the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, researchers are hopeful that one day the procedure could be used to develop a new life-saving therapy.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.